Effects of Dexmedetomidine on the RhoA /ROCK/ Nox4 Signaling Pathway in Renal Fibrosis of Diabetic Rats

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2019 Dec 18

PMID 31844679

Citations 5

Authors

Chen Jihua

Chen Cai

Bao Xubin

Yu Yue

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effects and mechanisms of dexmedetomidine (Dex) on model rats of diabetic nephropathy (DN).

Methods: Rats were divided into NC, model, Dex-L (1μg/ kg), Dex-M (5μg/kg) and Dex-H (10μg/kg) groups. Rats in all groups except in the NC group were injected with streptozotocin (STZ) combined with right nephrectomy. Rats in Dex (1, 5 and 10μg/kg) groups received gavage with Dex (1, 5 and 10μg/kg). After 4 weeks, rats were sacrificed and kidneys were collected. HE staining was performed for a renal injury. Masson staining was applied to detect the fibrotic accumulation in rat kidney. Radioimmunoassay was used to test the renal function. Immunohistochemical method was used to detect protein expressions of RhoA, p-MYPT and Nox4 in rat kidney.

Results: Compared with the NC group, the levels of urine microalbumin in protein, α1-MG and β2-MG, renal fibrotic accumulation, RhoA, p-MYPT, Nox4 and α-SMA in model group increased significantly (P＜0.001, respectively). Compared with the model group, Dex low, medium and high groups improved the deposition of renal fiber in rats, inhibited the expression levels of microalbumin, α1-MG and β2-MG in urine and decreased expression of RhoA, p-MYPT, Nox4 and α-SMA proteins (P＜0.05, P＜0.01).

Conclusion: Dex is possible to inhibit the expression of α-SMA and renal fibrous substance deposition in rat kidney via RhoA/ROCK/Nox4 signaling pathway, thereby reducing early kidney damage in model rats.

Citing Articles

WTAP-mediated mA modification of TRIM22 promotes diabetic nephropathy by inducing mitochondrial dysfunction via ubiquitination of OPA1.

Zhang Z, Zhou F, Lu M, Zhang D, Zhang X, Xu S Redox Rep. 2024; 29(1):2404794.

PMID: 39314036 PMC: 11423538. DOI: 10.1080/13510002.2024.2404794.

Dapagliflozin can alleviate renal fibrosis in rats with streptozotocin‑induced type 2 diabetes mellitus.

Xue S, Li Y, Lu X, Tang W Exp Ther Med. 2023; 26(6):572.

PMID: 38023356 PMC: 10652239. DOI: 10.3892/etm.2023.12271.

Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-B Signaling Pathway.

Zhou Y, Du X, Wang Q, Xiao S, Zhi J, Gao H Mediators Inflamm. 2023; 2023:3695469.

PMID: 36846195 PMC: 9946744. DOI: 10.1155/2023/3695469.

Dexmedetomidine Protects Against Kidney Fibrosis in Diabetic Mice by Targeting miR-101-3p-Mediated EndMT.

Song L, Feng S, Yu H, Shi S Dose Response. 2022; 20(1):15593258221083486.

PMID: 35370507 PMC: 8973067. DOI: 10.1177/15593258221083486.

Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, in part by inhibiting the RhoA/ROCK pathway, in a UUO rat model.

Shi Z, Wang Q, Zhang Y, Jiang D Stem Cell Res Ther. 2020; 11(1):253.

PMID: 32586368 PMC: 7318505. DOI: 10.1186/s13287-020-01767-8.

References

Huang W, Fu Q, Xiao Y, Gong Q, Wu W, Shen Z . Effect of Qufengtongluo Decoction on PI3K/Akt Signaling Pathway in the Kidney of Type 2 Diabetes Mellitus Rat (GK Rat) with Diabetic Nephropathy. Evid Based Complement Alternat Med. 2018; 2018:8421979. PMC: 5820584. DOI: 10.1155/2018/8421979. View

Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K . Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: a report from a collaborative initiative by six Japanese associations. Diabetol Int. 2019; 10(2):85-92. PMC: 6506512. DOI: 10.1007/s13340-019-00389-7. View

Dieterle F, Perentes E, Cordier A, Roth D, Verdes P, Grenet O . Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 2010; 28(5):463-9. DOI: 10.1038/nbt.1622. View

Ridley A . Rho family proteins: coordinating cell responses. Trends Cell Biol. 2001; 11(12):471-7. DOI: 10.1016/s0962-8924(01)02153-5. View

Andreucci M, Faga T, Pisani A, Perticone M, Michael A . The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med. 2016; 39:1-8. DOI: 10.1016/j.ejim.2016.12.001. View

Breyer M, Kretzler M . Novel avenues for drug discovery in diabetic kidney disease. Expert Opin Drug Discov. 2017; 13(1):65-74. DOI: 10.1080/17460441.2018.1398731. View

Spoelstra-de Man A, Oudemans-van Straaten H . Acute kidney injury after cardiac arrest: the role of coronary angiography and temperature management. Crit Care. 2019; 23(1):193. PMC: 6543686. DOI: 10.1186/s13054-019-2476-8. View

Furukawa M, Gohda T, Tanimoto M, Tomino Y . Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy. ScientificWorldJournal. 2013; 2013:928197. PMC: 3655660. DOI: 10.1155/2013/928197. View

Peng F, Wu D, Gao B, Ingram A, Zhang B, Chorneyko K . RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes. 2008; 57(6):1683-92. DOI: 10.2337/db07-1149. View

10.

Xie X, Peng J, Huang K, Huang J, Shen X, Liu P . Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells. Mol Cell Endocrinol. 2012; 362(1-2):183-93. DOI: 10.1016/j.mce.2012.06.008. View

11.

Sutariya B, Saraf M . Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway. J Ethnopharmacol. 2017; 198:432-443. DOI: 10.1016/j.jep.2016.12.048. View

12.

Zhang X, Guo K, Xia F, Zhao X, Huang Z, Niu J . FGF23 improves diabetic nephropathy by attenuating renal fibrosis and inflammation. BMC Biotechnol. 2018; 18(1):33. PMC: 5975516. DOI: 10.1186/s12896-018-0449-7. View

13.

Adhya P, Sharma S . Redox TRPs in diabetes and diabetic complications: Mechanisms and pharmacological modulation. Pharmacol Res. 2019; 146:104271. DOI: 10.1016/j.phrs.2019.104271. View

14.

Tikoo K, Sharma E, Amara V, Pamulapati H, Dhawale V . Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction. J Biol Chem. 2016; 291(42):21848-21856. PMC: 5063970. DOI: 10.1074/jbc.C116.732990. View

15.

Seo M, Li H, An J, Jang J, Jung H, Kim T . The vasodilatory effect of the antidiabetic drug linagliptin via inhibition of Rho-associated protein kinase in aortic smooth muscle. Life Sci. 2019; 219:1-10. DOI: 10.1016/j.lfs.2019.01.004. View

16.

Mariappan M . Signaling mechanisms in the regulation of renal matrix metabolism in diabetes. Exp Diabetes Res. 2012; 2012:749812. PMC: 3290898. DOI: 10.1155/2012/749812. View